AROG Pharmaceuticals, Inc

Industry

  • Pharmaceuticals
  • Biotechnology
See more in Biomedtracker

Latest on AROG Pharmaceuticals, Inc

Scrip

Daiichi Eyes First-Line AML Filings For Vanflyta On Positive Data

 
• By Lisa Takagi

Daiichi Sankyo Co., Ltd. looks set to press ahead with approval filings in major markets for its oral FLT3 inhibitor Vanflyta (quizartinib) in first-line FLT3-ITD-positive acute myeloid leukemia (AML

Scrip

A Dramatically Changing Landscape In Acute Myeloid Leukemia

 
• By John Davis

Since 2017, nine new drugs have been approved for acute myeloid leukemia (AML) in the US, dramatically changing the treatment landscape, with the condition benefiting from breakthroughs in the underst